Anti-COVID drug developed by Vancouver company gets emergency use approval in Canada

South Africa News News

Anti-COVID drug developed by Vancouver company gets emergency use approval in Canada
South Africa South Africa Latest News,South Africa South Africa Headlines

Approval comes as AbCellera Biologics prepares to go public in a move that would likely value the company at several billion dollars.

  • ๐Ÿ“ฐ nationalpost
  • โฑ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • ๐Ÿ“Š Quality Score:
  • News: 11%
  • Publisher: 80%

In a prepared statement, AbCellera founder and chief executive Carl Hansen said Health Canada had granted authorization for the use of bamlanivimab to treat people over the age of 12 with mild and moderate COVID-19 symptoms who were at high risk of the disease progressing.

AbCellera is entitled to receive a specified percentage of proceeds that Lilly receives from these sales. According to Bloomberg News, AbCellera is expected to be worth several billion dollars after it is publicly listed. AbCellera researchers used a blood sample from one of the earliest COVID-19 survivors from the U.S. to get their work started.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

nationalpost /  ๐Ÿ† 10. in ZA
 

According to Latest 2nd Wave Numbers. 0.7117% of Ontario's Population has Tested Positive to Date (up from 0.7012%) That Leaves Only 99.2882% Having Not Tested Positive (down from 99.2987%) MSMDefcon101 ๐Ÿ˜œ๐ŸŽˆ๐Ÿคกโ„๏ธ ArmageddonWatchzzzz

And wasnโ€™t this drug used on Trump, no mention of that from MSM

South Africa South Africa Latest News, South Africa South Africa Headlines



Render Time: 2025-01-16 06:11:43